Liu C, He D, Cen H, Chen H, Li L, Nie G
Extracell Vesicles Circ Nucl Acids. 2024; 3(1):14-30.
PMID: 39697871
PMC: 11648500.
DOI: 10.20517/evcna.2021.21.
Ubanako P, Mirza S, Ruff P, Penny C
Front Mol Biosci. 2024; 11:1447953.
PMID: 39355533
PMC: 11442288.
DOI: 10.3389/fmolb.2024.1447953.
Sai B, Dinakar Y, Kumar H, Jain R, Kesharwani S, Kesharwani S
Ther Deliv. 2024; 15(11):871-891.
PMID: 39320858
PMC: 11498026.
DOI: 10.1080/20415990.2024.2400044.
Rastgar A, Kheyrandish S, Vahidi M, Heidari R, Ghorbani M
Mol Biol Rep. 2024; 51(1):737.
PMID: 38874790
DOI: 10.1007/s11033-024-09650-y.
Peniche Silva C, Balmayor E, van Griensven M
Front Bioeng Biotechnol. 2024; 12:1379773.
PMID: 38784762
PMC: 11112497.
DOI: 10.3389/fbioe.2024.1379773.
Advances in Engineered Nanoparticles for the Treatment of Ischemic Stroke by Enhancing Angiogenesis.
Wang G, Li Z, Wang G, Sun Q, Lin P, Wang Q
Int J Nanomedicine. 2024; 19:4377-4409.
PMID: 38774029
PMC: 11108071.
DOI: 10.2147/IJN.S463333.
Spermine-Based Poly(β-amino ester)s for siRNA Delivery against Mutated KRAS in Lung Cancer.
Jin Y, Adams F, Isert L, Baldassi D, Merkel O
Mol Pharm. 2023; 20(9):4505-4516.
PMID: 37578116
PMC: 7615020.
DOI: 10.1021/acs.molpharmaceut.3c00206.
Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems.
Yun W, Kim J, Lim D, Kim D, Jeon S, Kim K
Nanomaterials (Basel). 2023; 13(15).
PMID: 37570543
PMC: 10421122.
DOI: 10.3390/nano13152225.
Roles of Non-Coding RNA in Alzheimer's Disease Pathophysiology.
Olufunmilayo E, Holsinger R
Int J Mol Sci. 2023; 24(15).
PMID: 37569871
PMC: 10420049.
DOI: 10.3390/ijms241512498.
Cationic Polymers as Transfection Reagents for Nucleic Acid Delivery.
Cai X, Dou R, Guo C, Tang J, Li X, Chen J
Pharmaceutics. 2023; 15(5).
PMID: 37242744
PMC: 10223806.
DOI: 10.3390/pharmaceutics15051502.
Smuggling on the Nanoscale-Fusogenic Liposomes Enable Efficient RNA-Transfer with Negligible Immune Response In Vitro and In Vivo.
Hoffmann M, Gerlach S, Takamiya M, Tarazi S, Hersch N, Csiszar A
Pharmaceutics. 2023; 15(4).
PMID: 37111695
PMC: 10146161.
DOI: 10.3390/pharmaceutics15041210.
Oncogene Silencing in a Breast Cancer Cell Model Using Cationic Lipid-Based Delivery Systems.
Balgobind A, Daniels A, Ariatti M, Singh M
Pharmaceutics. 2023; 15(4).
PMID: 37111675
PMC: 10142055.
DOI: 10.3390/pharmaceutics15041190.
Oral delivery of RNAi for cancer therapy.
Afrin H, Bai R, Kumar R, Ahmad S, Agarwal S, Nurunnabi M
Cancer Metastasis Rev. 2023; 42(3):699-724.
PMID: 36971908
PMC: 10040933.
DOI: 10.1007/s10555-023-10099-x.
Development of Novel siRNA Therapeutics: A Review with a Focus on Inclisiran for the Treatment of Hypercholesterolemia.
Ebenezer O, Comoglio P, Wong G, Tuszynski J
Int J Mol Sci. 2023; 24(4).
PMID: 36835426
PMC: 9966809.
DOI: 10.3390/ijms24044019.
Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA.
Zhao J, Mu X, Hou X, Zhang X, Li P, Jiang J
Front Oncol. 2023; 13:1111855.
PMID: 36756155
PMC: 9900173.
DOI: 10.3389/fonc.2023.1111855.
Investigation of the ionic conditions in SiRNA-mediated delivery through its carriers in the cell membrane: a molecular dynamic simulation.
Darvishi M, Allahverdi A, Hashemzadeh H, Javadi H
Sci Rep. 2022; 12(1):17520.
PMID: 36266467
PMC: 9582388.
DOI: 10.1038/s41598-022-22509-1.
Insights on prospects of nano-siRNA based approaches in treatment of Cancer.
Goyal R, Chopra H, Singh I, Dua K, Gautam R
Front Pharmacol. 2022; 13:985670.
PMID: 36091772
PMC: 9452808.
DOI: 10.3389/fphar.2022.985670.
A Combination Therapy Using Electrical Stimulation and Adaptive, Conductive Hydrogels Loaded with Self-Assembled Nanogels Incorporating Short Interfering RNA Promotes the Repair of Diabetic Chronic Wounds.
Lei H, Fan D
Adv Sci (Weinh). 2022; 9(30):e2201425.
PMID: 36064844
PMC: 9596839.
DOI: 10.1002/advs.202201425.
siRNA-based nanotherapeutics as emerging modalities for immune-mediated diseases: A preliminary review.
Sargazi S, Arshad R, Ghamari R, Rahdar A, Bakhshi A, Karkan S
Cell Biol Int. 2022; 46(9):1320-1344.
PMID: 35830711
PMC: 9543380.
DOI: 10.1002/cbin.11841.
New paradigm in combination therapy of siRNA with chemotherapeutic drugs for effective cancer therapy.
Kumar K, Rani V, Mishra M, Chawla R
Curr Res Pharmacol Drug Discov. 2022; 3:100103.
PMID: 35586474
PMC: 9108887.
DOI: 10.1016/j.crphar.2022.100103.